Investor Presentaiton

Debt Profile Particulars 31/03/19 30/09/19 Foreign Currency Loans ($ Mn) ($ Mn) Subsidiaries 500 Total 500 500 Rupee Loans Standalone Subsidiaries 30/12/19 ($ Mn) 400 500 400 (Rs. Crs) (Rs. Crs) (Rs. Crs) 1,156 1,341 61 1,402 1,029 21 1,050 37 Total 1,193 Gross Debt (Rs. Crs) (Rs. Crs) (Rs. Crs) Standalone 1,341 1,029 1,156 Subsidiaries Total QoQ Change Cumulative Change 3,519 3,565 2,893 4,860 4,594 4,048 (8) (546) (266) (812) Cash & Equivalent 1,370 1,363 687 Net Debt (before Fx Adjustment) 3,490 3,231 3,362 QoQ Change (56) 131 Change in debt on account of Fx rate (86) (89) difference from 31-March, 2019 Net Debt (On a Constant Currency Basis) 3,490 3,145 3,273 QoQ Change (149) 128 Cumulative Change (345) (217) Closing Exchange Rate (USD/Rs.) 69.16 70.88 71.39 ■ Partial early redemption of USD 100 million of high yield bonds issued by Jubilant Pharma Limited due in 2021 at a redemption price of 102.4375% along with accrued interest during the quarter ■ Early Redemption of Non-Convertible Debentures of Rs 745 Crore in January 2020 ■ Net Debt reduction of Rs 217 Crore in 9M'FY20 as compared to March 31, 2019 and increase of Rs 128 Crore in Q3'FY20 Average blended interest rate for 9M'FY20 @ 6.08%; INR loans @ 8.21% and USD loans @ 5.34% ☐ JLIFES LIFESCIENCES

View entire presentation